Finding the right balance

CRISPR, or clustered regularly interspaced short palindromic repeats, has been hailed as one of the most game-changing advances in genetic technology and perhaps even all of science.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Teva can pursue monopoly claims over rival’s ‘exclusive pharmacy deal’

7 May 2026 A California judge has denied Corcept’s bid to dismiss the lawsuit over its drug for a rare hormonal disorder, allowing the litigation to proceed on all core counts.

Americas

US judge allows rare patent defence in ‘world’s smallest heart pump’ suit

5 May 2026 J&J’s Abiomed can proceed with its non-infringement defence despite potential future appellate reversal, in a week when both parties in the case were dealt wins and losses in their clash over Impella devices.

Americas

WATCH: Interview with Ben Doranz, president and CEO, Integral Molecular

4 May 2026 LSIPR's senior reporter Marisa Woutersen speaks with Ben Doranz of Integral Molecular, fresh from the stage at LSPN Boston after speaking at a panel session on challenges in antibody patent protection.

More features

Teva can pursue monopoly claims over rival’s ‘exclusive pharmacy deal’

Kilpatrick adds tech patent litigator and China expert to Chicago office

US judge allows rare patent defence in ‘world’s smallest heart pump’ suit

WATCH: Interview with Ben Doranz, president and CEO, Integral Molecular

Brussels under scrutiny for IP policy as US flags risks to innovation

From the courtroom: Hikma v Amarin SCOTUS oral arguments

Report: 85% of in-house counsel want IP service providers to embrace AI

Boston-based patent expert departs Mintz for major West Coast firm

Finding the right balance

More on this story

Editor's picks

Editor's picks

More features